[go: up one dir, main page]

IL121407A0 - Substituted indanylidineacetylguanidines process for their preparation their use as medicaments or in diagnosis and medicaments containing them - Google Patents

Substituted indanylidineacetylguanidines process for their preparation their use as medicaments or in diagnosis and medicaments containing them

Info

Publication number
IL121407A0
IL121407A0 IL12140797A IL12140797A IL121407A0 IL 121407 A0 IL121407 A0 IL 121407A0 IL 12140797 A IL12140797 A IL 12140797A IL 12140797 A IL12140797 A IL 12140797A IL 121407 A0 IL121407 A0 IL 121407A0
Authority
IL
Israel
Prior art keywords
medicaments
indanylidineacetylguanidines
diagnosis
substituted
preparation
Prior art date
Application number
IL12140797A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL121407A0 publication Critical patent/IL121407A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C327/54—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL12140797A 1996-07-30 1997-07-28 Substituted indanylidineacetylguanidines process for their preparation their use as medicaments or in diagnosis and medicaments containing them IL121407A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96112275A EP0837055A1 (en) 1996-07-30 1996-07-30 Substituted Indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them

Publications (1)

Publication Number Publication Date
IL121407A0 true IL121407A0 (en) 1998-01-04

Family

ID=8223055

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12140797A IL121407A0 (en) 1996-07-30 1997-07-28 Substituted indanylidineacetylguanidines process for their preparation their use as medicaments or in diagnosis and medicaments containing them

Country Status (29)

Country Link
US (1) US5900436A (es)
EP (2) EP0837055A1 (es)
JP (1) JP4039589B2 (es)
KR (1) KR980009236A (es)
CN (1) CN1064351C (es)
AR (1) AR008095A1 (es)
AT (1) ATE207888T1 (es)
AU (1) AU715187B2 (es)
BR (1) BR9704131A (es)
CA (1) CA2211982C (es)
CZ (1) CZ241197A3 (es)
DE (1) DE69707777T2 (es)
DK (1) DK0822182T3 (es)
ES (1) ES2164283T3 (es)
HR (1) HRP970424B1 (es)
HU (1) HUP9701316A3 (es)
ID (1) ID17565A (es)
IL (1) IL121407A0 (es)
MX (1) MX9705737A (es)
NO (1) NO308213B1 (es)
NZ (1) NZ328440A (es)
PL (1) PL321392A1 (es)
PT (1) PT822182E (es)
RU (1) RU2176638C2 (es)
SI (1) SI0822182T1 (es)
SK (1) SK282128B6 (es)
TR (1) TR199700704A2 (es)
TW (1) TW445251B (es)
ZA (1) ZA976735B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
SI2384318T1 (en) 2008-12-31 2018-03-30 Ardelyx, Inc. MEASURES AND PROCEDURES FOR THE INHIBITION OF ANTIPORT INHIBITED BY NHE IN THE TREATMENT OF DISEASES RELATED TO STRENGTH OF FLAMMABILITY OR TRADEMARITY WITH SOLO, AND THE EMISSION OF GASTROINTESTINAL TREATMENT
GB0916163D0 (en) * 2009-09-15 2009-10-28 Shire Llc Prodrugs of guanfacine
MX382203B (es) 2013-04-12 2025-03-11 Ardelyx Inc Compuestos de union a nhe3 (intercambiador de sodio-hidrogeno 3) y metodos para inhibir transporte de fosfato.
UA126283C2 (uk) 2017-01-09 2022-09-14 Арделікс, Інк. Сполуки, придатні для лікування розладів шлунково-кишкового тракту
JP2020505333A (ja) 2017-01-09 2020-02-20 アルデリックス， インコーポレイテッド Ｎｈｅ媒介性アンチポートの阻害薬
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
CN116492469A (zh) * 2023-05-22 2023-07-28 遵义医科大学附属医院 一种通道阻滞剂在制备治疗和/或预防肝纤维疾病药物中的应用
CN119118881B (zh) * 2024-07-25 2026-01-02 中国农业大学 含胍基的5-氯茚满化合物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DE4421536A1 (de) * 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
SI0738712T1 (en) * 1995-04-18 1999-12-31 Hoechst Aktiengesellschaft Anti-arrhythmic and cardioprotective substituted indenoylguanidines

Also Published As

Publication number Publication date
NZ328440A (en) 1997-11-24
ID17565A (id) 1998-01-08
PL321392A1 (en) 1998-02-02
ATE207888T1 (de) 2001-11-15
TR199700704A2 (xx) 1998-02-21
TW445251B (en) 2001-07-11
DE69707777D1 (de) 2001-12-06
SI0822182T1 (en) 2002-04-30
DE69707777T2 (de) 2003-01-16
BR9704131A (pt) 1998-12-29
JP4039589B2 (ja) 2008-01-30
CZ241197A3 (cs) 1998-02-18
PT822182E (pt) 2002-03-28
HRP970424A2 (en) 1998-06-30
CN1172104A (zh) 1998-02-04
NO308213B1 (no) 2000-08-14
JPH1129545A (ja) 1999-02-02
HUP9701316A3 (en) 1998-07-28
HU9701316D0 (en) 1997-09-29
HUP9701316A2 (hu) 1998-03-02
AU715187B2 (en) 2000-01-20
SK282128B6 (sk) 2001-11-06
CA2211982A1 (en) 1998-01-30
ZA976735B (en) 1998-01-30
SK103497A3 (en) 1998-02-04
EP0837055A1 (en) 1998-04-22
DK0822182T3 (da) 2002-02-25
NO973486L (no) 1998-02-02
EP0822182B1 (en) 2001-10-31
CN1064351C (zh) 2001-04-11
NO973486D0 (no) 1997-07-29
KR980009236A (ko) 1998-04-30
EP0822182A1 (en) 1998-02-04
ES2164283T3 (es) 2002-02-16
CA2211982C (en) 2007-09-18
AU3155497A (en) 1998-02-05
MX9705737A (es) 1998-02-28
RU2176638C2 (ru) 2001-12-10
HRP970424B1 (en) 2002-06-30
AR008095A1 (es) 1999-12-09
US5900436A (en) 1999-05-04

Similar Documents

Publication Publication Date Title
SI0825178T1 (en) Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or in diagnostic agents and drugs containing them
IL129315A0 (en) Oxadiazoles process for their preparation and their use as medicaments
AP9901556A0 (en) Sulpponamide derivatives process for their preparation and their use as medicaments
ZA953501B (en) Erythromycin derivatives their preparation process and their use as medicaments
ZA952059B (en) Erythromycin derivatives their preparation process and their use as medicaments
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
HUP9800138A3 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives, process for producing them, pharmaceutical compositions containing the same and their use
SI0771788T1 (en) Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic and medicament containing them
CZ63895A3 (en) 5-vinyl-quinolone-carboxylic, 5-vinyl-naphthyridon-carboxylic, +5-ethinyl-quinolone-carboxylic and 5-ethinyl-naphthyridon-carboxylic acids, process of their preparation, medicaments in which said compounds are comprised and their use
HRP970292A2 (en) Substituted 2-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicament containing them
IL118278A0 (en) Substituted benzyloxycarbonyl-guanidines process for their preparation their use as a medicament or diagnostic and medicament containing them
GB9416467D0 (en) Compounds for use in medicine
IL121407A0 (en) Substituted indanylidineacetylguanidines process for their preparation their use as medicaments or in diagnosis and medicaments containing them
ZA961231B (en) Substituted benzenesulfonyllureas and -thioureas process for their preparation their use as a medicament or diagnostic and medicament containing them
ZA968091B (en) Substituted benzolyguanidines a process for their preparation their use as a medicament or diagnostic agent and medicament comprising them
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
IL164513A0 (en) Pyrazolopyrimidines, pharmaceutical compositions containing them, and their use in the preparation of medicaments
GB9413090D0 (en) Benzazepine derivatives compositions containing them and their use in therapy
IL113415A0 (en) Dihydrodibenzoquinolinediones their preparation and use and pharmaceutical compositions containing them
IL120925A0 (en) Substituted 1-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them
ZA9711324B (en) Steroids substituted in position 11 their preparation process their use as medicaments and the pharmaceutical compounds containing them
IL120214A (en) Substituted thiophenylalkenyl-carboxylic acid guanidides process for their preparation their use as a medicament or diagnostic and medicaments containing them
IL114161A0 (en) Amido- quinoxalinediones pharmaceutical compositions containing them and their use
IL109436A0 (en) Quinolyl-dihydropyridine esters, processes for their preparation, and their use in pharmaceutical compositions
IL120093A0 (en) Substituted diaryldicarboxylic acid diguanidides processes for their preparation their use as a medicament or diagnostic and medicament containing them